| NO | ထုတ်ကုန်များ | CAS နံပါတ် | အဓိက အရည်အသွေး အညွှန်း | |||
| သန့်ရှင်းစင်ကြယ်ခြင်း။ | မက်တယ်။ စိတ်ညစ်ညူးခြင်း။ | စုစုပေါင်းပျော်ရည်အကြွင်းအကျန် | အစိုဓာတ် | |||
| 1 | Fmoc-β-Ala-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | Fmoc-D-Ala-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | Fmoc-β-Ala-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | Fmoc-Arg(pbf)-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | Fmoc-β-Ala-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | Fmoc-β-Ala-D-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | Fmoc-β-Ala-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | Fmoc-Asn(Trt)-Asn(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | Fmoc-β-Ala-Asn(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | Fmoc-Asp(OtBu)-Asp(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | Fmoc-β-Ala-Asp(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | Fmoc-Cys(Trt)-Cys(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | Fmoc-β-Ala-Cys(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | Fmoc-Cys(Acm)-Cys(Acm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | Fmoc-β-Ala-Cys(Acm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | Fmoc-Gln(Trt)-Gln(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | Fmoc-β-Ala-Gln(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | Fmoc-Glu(OtBu)-Glu(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | Fmoc-β-Ala-Glu(OtBu)-OH.H2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | Fmoc-β-Ala-Gly-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | Fmoc-His(Trt)-His(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | Fmoc-β-Ala-His(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | Fmoc-Ile-Ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | Fmoc-β-Ala-Ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | Fmoc-Leu-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | Fmoc-β-Ala-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | Fmoc-D-Leu-D-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | Fmoc-β-Ala-D-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | Fmoc-Lys(Boc)-Lys(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | Fmoc-β-Ala-Lys(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | Fmoc-Lys(Alloc)-Lys(Alloc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | Fmoc-β-Ala-Lys(Alloc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | Fmoc-Met-Met-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | Fmoc-β-Ala-Met-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | Fmoc-Orn(Boc)-Orn(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | Fmoc-β-Ala-Orn(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | Fmoc-Phe-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | Fmoc-β-Ala-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | Fmoc-D-Phe-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | Fmoc-β-Ala-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | Fmoc-Pro-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | Fmoc-β-Ala-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | Fmoc-Ser(tBu)-Ser(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | Fmoc-β-Ala-Ser(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | Fmoc-Ser(Trt)-Ser(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | Fmoc-β-Ala-Ser(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | Fmoc-Thr(tBu)-Thr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | Fmoc-β-Ala-Thr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | Fmoc-Trp(Boc)-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | Fmoc-β-Ala-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | Fmoc-β-Ala-D-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | Fmoc-Tyr(tBu)-Tyr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | Fmoc-β-Ala-Tyr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | Fmoc-β-Ala-D-Tyr(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | Fmoc-Tyr(Me)-Tyr(Me)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | Fmoc-β-Ala-Tyr(Me)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | Fmoc-Val-Val-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | Fmoc-β-Ala-Val-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | Fmoc-D-Cit-D-Cit-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | Fmoc-β-Ala-D-Cit-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | Fmoc-β-Ala-Dab-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | Fmoc-(3-(2-naphthyl)-D-Ala)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | Fmoc-β-Ala-3-(2-naphthyl)-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | Fmoc-(3-(3-pyridinyl)-D-Ala)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | Fmoc-β-Ala-3-(3-pyridinyl)-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | Fmoc-(4-chloro-D-Phe)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | Fmoc-β-Ala-4-chloro-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | Fmoc-(D-4Aph(tBuCbm))2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | Fmoc-β-Ala-D-4Aph(tBuCbm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | Fmoc-β-Ala-Aph(L-Hor)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | Fmoc-β-Ala-Lys(iPr၊Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | Fmoc-β-Ala-AEEA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | Fmoc-Aib-Aib-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | Fmoc-β-Ala-Aib-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | Fmoc-Arg-OH | ၉၁၀၀၀-၆၉-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H-Arg(pbf)-OH | ၂၀၀၁၁၅-၈၆-၂ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | Fmoc-D-Arg-OH | ၁၃၀၇၅၂-၃၂-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-Arg(pbf)-OH | ၂၀၀၁၁၆-၈၁-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | Fmoc-HomoArg-OH.HCl | ၂၀၈၁၇၄-၁၄-၅ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | Fmoc-D-HomoArg-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | Fmoc-Asn-OH | ၇၁၉၈၉-၁၆-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H-Asn(Trt)-OH | ၁၃၂၃၈၈-၅၈-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | Fmoc-Asp-OH | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-Asp(OtBu)-OH | ၃၀၅၇-၇၄-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | Fmoc-Cys-OH | ၁၃၅၂၄၈-၈၉-၄ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-Cys(Trt)-OH | ၂၇၉၉/၇/၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-Cys(Acm)-OH.HCl | ၂၈၇၉၈-၂၈-၉ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | Fmoc-Gln-OH | ၇၁၉၈၉-၂၀-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-Gln(Trt)-OH | ၁၀၂၇၄၇-၈၄-၂ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | Fmoc-Glu-OH | ၁၂၁၃၄၃-၈၂-၆ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-Glu(OtBu)-OH.H2O | ၂၄၁၉-၅၆-၉ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၀ | Fmoc-His-OH | ၁၁၆၆၁၁-၆၄-၄ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၁ | H-His(Trt)-OH | ၃၅၁၄၆-၃၂-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၂ | Boc-His-OH | ၁၇၇၉၁-၅၂-၅ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၃ | Fmoc-Lys-OH | ၁၀၅၀၄၇-၄၅-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၄ | H-Lys(Boc)-OH | ၂၄၁၈-၉၅-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၅ | H-Lys(Alloc)-OH | ၆၂၉၈/၃/၉ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၆ | Fmoc-Orn-OH.HCl | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၇ | H-Orn(Boc)-OH | ၁၃၆၅၀-၄၉-၂ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၈ | Fmoc-Ser-OH | ၇၃၇၂၄-၄၅-၅ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၀၉ | H-Ser(tBu)-OH | ၁၈၈၂၂-၅၈-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၀ | H-Ser(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၁ | Fmoc-Thr-OH.H2O | ၇၃၇၃၁-၃၇-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၂ | H-Thr(tBu)-OH | ၄၃၇၈-၁၃-၆ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၃ | Fmoc-Trp-OH | ၃၅၇၃၇-၁၅-၆ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၄ | H-Trp(Boc)-OH | ၁၄၆၆၄၅-၆၃-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၅ | Fmoc-D-Trp-OH | ၈၆၁၂၃-၁၁-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၆ | HD-Trp(Boc)-OH | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၇ | Fmoc-Tyr-OH | ၉၂၉၅၄-၉၀-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၈ | H-Tyr(tBu)-OH | ၁၈၈၂၂-၅၉-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၁၉ | Fmoc-D-Tyr-OH | ၁၁၂၈၈၃-၂၉-၁ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၂၀ | HD-Tyr(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၂၁ | H-Tyr(Me)-OH.HCl | ၆၇၄၂၃-၄၄-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၂၂ | Fmoc-D-4Aph(Cbm)-OH | ၃၂၄၀၁၇-၂၂-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၂၃ | HD-4Aph(tBuCbm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၂၄ | Fmoc-Lys(iPr)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| ၁၂၅ | H-Lys(iPr၊Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
လျော်ကြေးငွေ
Gentolex သည် အရည်အသွေးကောင်းမွန်သော ထုတ်ကုန်များကို ပံ့ပိုးပေးသည်၊ လုံလောက်သောအထောက်အထားများဖြင့် သုံးစွဲသူမှ လိုအပ်သောအချိန်ဘောင်အတွင်း ကုန်ပစ္စည်းအရည်အသွေးကို မြှင့်တင်ပါက လျော်ကြေး၏လုပ်ထုံးလုပ်နည်းများကို အစပျိုးရန် လိုအပ်သော ခွဲခြမ်းစိတ်ဖြာမှုနှင့် အကဲဖြတ်မှုများကို ဆောင်ရွက်ပေးပါမည်။
ထုတ်လုပ်မှု
ဆေးဝါးထုတ်ကုန်များ၏ စွမ်းဆောင်နိုင်ရည်သည် တန်တန်းအဆင့်သို့ရောက်ရှိပြီး၊ ဓာတုဗေဒထုတ်ကုန်များ၏ စွမ်းဆောင်ရည်များသည် တန်ချိန် 100+ အဆင့်အထိရောက်ရှိကာ ကမ္ဘာတစ်ဝှမ်းရှိ သုံးစွဲသူများအား ဝန်ဆောင်မှုပေးနိုင်ရန် စွမ်းရည်များ ကောင်းစွာတပ်ဆင်ထားပါသည်။
သုတေသနနှင့် ဖွံ့ဖြိုးတိုးတက်ရေး
နှစ်စဉ်နှစ်တိုင်း R&D အဖွဲ့မှ ကွဲပြားခြားနားသော ထုတ်ကုန်အသစ်များ တီထွင်ထုတ်လုပ်ရန် အစီအစဥ်ရှိပြီး၊ ရည်မှန်းချက်များချမှတ်ထားသည့်အခါတွင်၊ အဖွဲ့အတွင်းရှိအဖွဲ့ဝင်တိုင်းသည် KPI တာဝန်နှင့် မက်လုံးပေါ်လစီဖြင့် ဆက်လက်လုပ်ဆောင်ရမည်ဖြစ်ပါသည်။